Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahfouz, A. E.
Right arrow Articles by Wolf, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahfouz, A. E.
Right arrow Articles by Wolf, K. J.

Radiology, Vol 190, 49-52, Copyright © 1994 by Radiological Society of North America


ARTICLES

Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions

AE Mahfouz, B Hamm and KJ Wolf
Department of Radiology, Klinikum Steglitz, Freie Universitat Berlin, Germany.

PURPOSE: To assess the value of peripheral washout of contrast medium in differentiating benign from malignant focal liver lesions. MATERIALS AND METHODS: One hundred two patients, 49 with malignant liver tumors and 53 with benign lesions, underwent unenhanced T1- and T2-weighted and dynamic gadolinium-enhanced magnetic resonance (MR) imaging. Dynamic contrast material-enhanced MR imaging was performed before and up to 10 minutes after intravenous administration of a bolus of gadopentetate dimeglumine (0.1 mmol/kg). RESULTS: On the dynamic contrast-enhanced images, 12 of the 49 malignant tumors had a rim that was hypo-intense to the center of the lesion ("peripheral washout" sign); this rim was best seen 10 minutes after administration of contrast material. This sign was absent in the remaining 37 malignant tumors as well as in all 53 benign lesions (P < .001). The peripheral washout sign had a sensitivity of 24.5% and a specificity of 100% in the diagnosis of malignancies of the liver. The malignant tumors with peripheral washout showed no difference in signal intensity between the periphery and the center on the unenhanced T1- and T2-weighted images. CONCLUSION: Peripheral washout is a specific sign of malignancy in dynamic gadolinium-enhanced MR imaging of liver lesions.


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. D. Beaty, A. C. Silva, and G. DePetris
AJR Teaching File: Incidental Hepatic Mass
Am. J. Roentgenol., June 1, 2008; 190(6_Supplement): S62 - S64.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
K. M. Elsayes, V. R. Narra, Y. Yin, G. Mukundan, M. Lammle, and J. J. Brown
Focal Hepatic Lesions: Diagnostic Value of Enhancement Pattern Approach with Contrast-enhanced 3D Gradient-Echo MR Imaging
RadioGraphics, September 1, 2005; 25(5): 1299 - 1320.
[Abstract] [Full Text] [PDF]


Home page
ImagingHome page
P Manoharan and J Ward
MRI in the assessment of focal liver lesions in the non-cirrhotic patient
Imaging, September 1, 2004; 16(4): 338 - 350.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M. Brannigan, P. N. Burns, and S. R. Wilson
Blood Flow Patterns in Focal Liver Lesions at Microbubble-enhanced US
RadioGraphics, July 1, 2004; 24(4): 921 - 935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
I.-M. Danet, R. C. Semelka, P. Leonardou, L. Braga, G. Vaidean, J. T. Woosley, and M. Kanematsu
Spectrum of MRI Appearances of Untreated Metastases of the Liver
Am. J. Roentgenol., September 1, 2003; 181(3): 809 - 817.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. C. Carlos, H. M. Kim, H. K. Hussain, I. R. Francis, H. V. Nghiem, and A. M. Fendrick
Developing a Prediction Rule to Assess Hepatic Malignancy in Patients with Cirrhosis
Am. J. Roentgenol., April 1, 2003; 180(4): 893 - 900.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. C. Mueller, H. K. Hussain, R. C. Carlos, H. V. Nghiem, and I. R. Francis
Effectiveness of MR Imaging in Characterizing Small Hepatic Lesions: Routine Versus Expert Interpretation
Am. J. Roentgenol., March 1, 2003; 180(3): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. C. Semelka and T. K. G. Helmberger
Contrast Agents for MR Imaging of the Liver
Radiology, January 1, 2001; 218(1): 27 - 38.
[Abstract] [Full Text]


Home page
RadiologyHome page
R. A. Kubik-Huch, N. M. Gottstein-Aalame, T. Frenzel, B. Seifert, E. Puchert, S. Wittek, and J. F. Debatin
Gadopentetate Dimeglumine Excretion into Human Breast Milk during Lactation
Radiology, August 1, 2000; 216(2): 555 - 558.
[Abstract] [Full Text]


Home page
Am. J. Roentgenol.Home page
W. K. Moon, K. H. Chang, H.-J. Weinmann, Y. H. Koh, J.-G. Im, K. M. Yeon, and M. C. Han
Dynamic Contrast-Enhanced MR Imaging of Bacterial Abscess and VX2 Carcinoma in Rabbits: Comparison of Gadopentetate Dimeglumine and a Macromolecular Contrast Agent
Am. J. Roentgenol., May 1, 2000; 174(5): 1385 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. T. Sica, H. Ji, and P. R. Ros
CT and MR Imaging of Hepatic Metastases
Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
G. L. Bennett, A. Petersein, W. W. Mayo-Smith, P. F. Hahn, W. Schima, and S. Saini
Addition of Gadolinium Chelates to Heavily T2-Weighted MR Imaging: Limited Role in Differentiating Hepatic Hemangiomas from Metastases
Am. J. Roentgenol., February 1, 2000; 174(2): 477 - 485.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1994 by the Radiological Society of North America.